Nanoscience enables ultrasensitive detection of Alzheimer's biomarker

Abstract excerpt

Alzheimer's disease (AD), which afflicts an estimated 16 million people worldwide, is a neurodegenerative dementia characterized by memory loss and cognitive impairment (1). Symptoms begin with mild cognitive impairment that cannot be distinguished from other more benign forms of age-related dementia. Even as the disease progresses, clinical diagnosis can be made with only 65–90% accuracy. AD cannot be...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Alzheimer's disease research and treatments
• Share to Computational Drug Discovery Methods
• Share to Neuroinflammation and Neurodegeneration Mechanisms